Clinical Feasibility of Mobile App-Based Self-Management for Breast Cancer-Related Lymphedema

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

58 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-04-11

Study Completion Date

2025-10-21

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The study evaluates a newly developed service that provides personalized self-management guidance based on evidence-based arm circumference measurements and resulting volume changes. The research aims to determine whether this digital solution is practical and acceptable for patients while identifying any unexpected challenges during implementation, ultimately establishing its potential for clinical integration into lymphedema care.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

The Validity and Reliability of Self Measurement of Upper Limb Volume

NCT01225783

Limb Volume Measurement

UNKNOWN NA

Early Detection and Intervention for Mild and Moderate Lymphedema in Patients Treated for Breast Cancer

NCT00959985

Lymphedema Breast Cancer

TERMINATED NA

The Impact of Lymphedema on Breast Cancer Survivors

NCT00769821

Breast Cancer Cancer Survivor Lymphedema +1 more

COMPLETED

Factors Associated With Health-related Quality of Life in Patients With Breast Cancer-Related Lymphedema Undergoing Prospective Surveillance

NCT07165275

Breast Cancer Related Lymphedema

COMPLETED

Auto-Adjustable MOBIDERM® Autofit NIGHT-time Compression Armsleeve in the Upper Limb LYMphedema in Maintenance Phase

NCT04203069

Lymphedema of Upper Arm

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Breast Cancer Related Lymphedema

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

digital health

Unilateral Upper Limb Lymphedema Associated with Breast Cancer

Group Type EXPERIMENTAL

digital health (Application and Smart Measuring Tape)

Intervention Type DEVICE

For lymphedema management, we use a smart measuring tape to measure arm circumference and provide analysis results along with self-management strategies.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

digital health (Application and Smart Measuring Tape)

For lymphedema management, we use a smart measuring tape to measure arm circumference and provide analysis results along with self-management strategies.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Between 18 and 70 years of age
* Diagnosed with breast cancer-related unilateral upper limb lymphedema
* Possessing an Android or iOS smartphone
* Voluntarily deciding to participate and providing written consent after receiving a detailed explanation of this study

Exclusion Criteria

* Diagnosed with malignant lymphedema due to metastasis or recurrence
* Having severe comorbidities (underlying diseases, neuromusculoskeletal disorders, cognitive, mental, or visual impairments, etc.) that make it difficult to use the application and participate in exercise interventions

Discontinuation Criteria:

* Development of serious complications or cancer metastasis/recurrence during the study period
* Occurrence of a serious illness unrelated to study participation
* Failure to follow the instructions of the study physician
* Voluntary withdrawal from the study or development of circumstances preventing participation

Minimum Eligible Age

18 Years

Maximum Eligible Age

70 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No